ISN-Baxter Extramural Grant Program

 

Foundation: 2001
Purpose: The program, called  Renal

Discoveries*, was designed to promote scientific discoveries in the field of kidney

disease. Supporting the study of all aspects of kidney

disease from pathophysiology to treatment options, Renal Discoveries provides much needed resources to enable researchers and

clinical investigators to pursue the broad long-term studies that are critical to

enhancing knowledge of kidney disease and its treatment.

Scholarships:
  • US $50,000 per year for three years

    of basic clinical research

  • US $75,000 per year for three years

    of applied clinical research.

  • Those granted an applied clinical

    research award are eligible to apply for increased funding up to US $300,000 in years two

    and three.

Funding: Baxter
Reviewers: ISN and

Baxter work together to determine potential research topics, which will be announced twice

each year, along with detailed writing instructions to guide applicants through the

process. An independent medical advisory board will evaluate applications based on

scientific merit. Baxter selects board members from among ISN’s membership. Board members will periodically rotate to ensure

breadth of scientific judgment.

Topics Treatment of severe congestive heart failure with peritoneal dialysis

Request for

proposals and writing instructions

Deadlines:

Application

deadline is 1 September 2003.

 

For more information on Renal Discoveries and

instructions for grant applications, please visit www.baxter.com/egp

 *Renal Discoveries is a trademark of

Baxter International Inc.

2002 MEDICAL ADVISORY BOARD

   

Robert C. Atkins, MBBS, MSc, DSc, FRACP—Clayton, Victoria, Australia

Tilman B. Dr?eke, MD —Paris, France

David C.H. Harris, MD, BS, FRACP—Westmead, NSW, Australia

J. Harold Helderman, MD, FACP—Nashville,

TN, USA

Lee W. Henderson, MD, FACP—Guilford, CT, USA

Walter H. H?rl, MD, PhD, FRCP—Vienna, Austria

Saulo Klahr, MD—St. Louis, MO, USA

William E. Mitch, MD—Atlanta, GA, USA

Sarah S. Prichard, MD, FRCP(C)—Montreal, Quebec, Canada

Peter Stenvinkel, MD, PhD—Stockholm, Sweden

 

Scroll to Top